Variant report
Variant | nsv998169 |
---|---|
Chromosome Location | chr3:68719218-68747401 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9813609 | chr3:68719218-68719219 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs529072633 | chr3:68719234-68719235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566623201 | chr3:68719236-68719237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145584256 | chr3:68719260-68719261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558763229 | chr3:68719283-68719284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575557207 | chr3:68719289-68719290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113060080 | chr3:68719317-68719318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557136948 | chr3:68719322-68719323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574080918 | chr3:68719348-68719349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371530911 | chr3:68719366-68719367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542626403 | chr3:68719370-68719371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559712460 | chr3:68719371-68719372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367826299 | chr3:68719396-68719397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112871874 | chr3:68719397-68719398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371852603 | chr3:68719494-68719495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375293106 | chr3:68719506-68719507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188115587 | chr3:68719507-68719508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565132152 | chr3:68719571-68719572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs367575875 | chr3:68719656-68719657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531047747 | chr3:68719660-68719661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573871317 | chr3:68719670-68719671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386662039 | chr3:68719671-68719672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200592729 | chr3:68719672-68719673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs58476444 | chr3:68719687-68719688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544662353 | chr3:68719689-68719690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs60398035 | chr3:68719691-68719692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201048059 | chr3:68719699-68719700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75633996 | chr3:68719702-68719703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551162787 | chr3:68719713-68719714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146959063 | chr3:68719758-68719759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149943954 | chr3:68735042-68735043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147613011 | chr3:68735044-68735045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142130983 | chr3:68735062-68735063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561013652 | chr3:68735081-68735082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556911239 | chr3:68735103-68735104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186317943 | chr3:68735139-68735140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573812179 | chr3:68735152-68735153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566800413 | chr3:68735167-68735168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550685077 | chr3:68735201-68735202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532546495 | chr3:68735205-68735206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377685675 | chr3:68735207-68735208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146563038 | chr3:68735216-68735217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2221394 | chr3:68735217-68735218 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs574895470 | chr3:68735234-68735235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574921021 | chr3:68735256-68735257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114799480 | chr3:68735327-68735328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555234595 | chr3:68735338-68735339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568137515 | chr3:68735342-68735343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116046799 | chr3:68735361-68735362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553831205 | chr3:68735397-68735398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Alcoholism | 21790672 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68716400-68719400 | Weak transcription | Aorta | Aorta |
2 | chr3:68718800-68719800 | Enhancers | Fetal Stomach | stomach |
3 | chr3:68719400-68719600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr3:68719400-68719600 | Enhancers | Aorta | Aorta |
5 | chr3:68735000-68735600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr3:68741200-68741600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr3:68741600-68744000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr3:68743600-68744200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr3:68744000-68744800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr3:68744000-68744800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |